美国二尖瓣再次手术的临床结局:STS国家数据库分析
基于STS国家数据库2011年7月至2016年9月17,195例有开胸手术史的孤立性二尖瓣手术成人患者,评估再次手术的死亡与并发症。总体手术死亡率6.6%,卒中2.4%,观察/预期死亡率比0.82;既往二尖瓣手术且择期、无内膜炎者死亡率3.4%。
要点
- 再次二尖瓣手术总体手术死亡率6.6%,卒中率2.4%。
- 既往二尖瓣手术、择期且无内膜炎者死亡率仅3.4%。
- 既往主动脉瓣置换增加死亡风险,手术入路不影响死亡率。
核心结论
- 尽管患者高危,再次二尖瓣手术的外科结局可接受,尤其既往二尖瓣手术且无内膜炎的择期患者。
研究设计与样本
- 基于STS国家数据库的回顾性队列研究,纳入2011年7月至2016年9月962个中心17,195例有开胸手术史的孤立性二尖瓣手术成人患者。
主要发现
- 总体手术死亡率6.6%,术后卒中2.4%,观察/预期死亡率比0.82。
- STS预测死亡风险8.0%,20%患者预测风险大于10%。
- 既往手术类型:二尖瓣手术61%、冠状动脉旁路移植39%、主动脉瓣手术18%、三尖瓣手术6%。
- 手术死亡最强独立预测因素包括挽救性手术、术前透析依赖、充血性心力衰竭、近期心肌梗死和活动性心内膜炎。
- 既往主动脉瓣置换与死亡风险增加相关,既往二尖瓣手术降低死亡风险,手术入路不影响死亡率。
临床怎么用
- 对既往二尖瓣手术、择期且无内膜炎患者,再次二尖瓣手术风险较低,可积极考虑。
- 术前需评估挽救性手术、透析依赖、心力衰竭、近期心肌梗死和活动性心内膜炎等高危因素。
- 既往主动脉瓣置换患者再次二尖瓣手术死亡风险增加,需加强围术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluated outcomes of reoperative mitral valve surgery (MVS) in the United States. METHODS: Adults undergoing isolated MVS with prior open-heart operation in The Society of Thoracic Surgeons (STS) National Database between July 2011 and September 2016 were included. Urgent or emergent operations as well as all indications and causes for MVS were included. Primary outcomes were operative mortality and morbidity. Multivariable models were used for risk-adjustment, incorporating variables from the STS Valve Risk Model as well as type of prior operation and reoperative approach. RESULTS: A total of 17,195 patients underwent isolated reoperative MVS at 962 centers. The STS predicted risk of mortality was 8.0%, with 20% having an STS predicted risk of mortality greater than 10%. Prior cardiac operations included previous MVS (61%), coronary artery bypass (39%), aortic valve surgery (18%), and tricuspid valve surgery (6%). Operative mortality for the overall study cohort was 6.6%, and postoperative stroke occurred in 2.4%. Observed-to-expected mortality for the overall cohort was 0.82. The strongest independent predictors of operative mortality included salvage operation, preoperative dialysis dependence, congestive heart failure, recent myocardial infarction, and active endocarditis. Prior aortic valve replacement was associated with increased mortality risk, whereas prior MVS reduced mortality risk. Surgical approach did not affect mortality. For patients with prior MVS undergoing elective, non-endocarditis operations, the operative mortality was 3.4%. CONCLUSIONS: Despite a high-risk patient profile, surgical outcomes of reoperative MVS were acceptable, particularly in patients with prior MVS and without endocarditis undergoing elective operations.
引用
- Kilic A, Acker MA, Gleason TG, et al. Clinical Outcomes of Mitral Valve Reoperations in the United States: An Analysis of The Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2018. PMID: 30365952. doi:10.1016/j.athoracsur.2018.08.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。